Bedel Financial Consulting, Inc. Baxter International Inc Transaction History

Bedel Financial Consulting, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$63.83 - $80.0 $3,255 - $4,080	-51 Closed	0 $0
Q2 2020 Jul 14, 2020	SELL	$78.66 - $94.14 $943 - $1,129	-12 Reduced 19.05%	51 $4,000
Q1 2020 May 06, 2020	BUY	$71.57 - $93.3 $858 - $1,119	12 Added 23.53%	63 $5,000
Q4 2019 Jan 28, 2020	BUY	$76.7 - $88.45 $2,837 - $3,272	37 Added 264.29%	51 $4,000
Q1 2018 May 03, 2018	BUY	$62.56 - $72.26 $875 - $1,011	14 New	14 $1,000

1,025

442M

4.22M

2.52M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.